Archives

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

P Preclinical data demonstrate ATR-01 delivers functional filaggrin, restoring skin barrier integrity and supporting advancement toward first-in-human studies BRANFORD, Conn., April 28, 2026 /PRNewswire/ —… Login to continue reading Login…

Read MoreAzitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

PharmaLogic announces opening of new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia

B ATLANTA, April 28, 2026 /PRNewswire/ — PharmaLogic Holdings Corp., (“PharmaLogic” or “the Company”), a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals,… Login to continue reading Login…

Read MorePharmaLogic announces opening of new PET radiopharmaceutical manufacturing facility in Atlanta, Georgia

Genezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial

P INDIANAPOLIS and LOS ANGELES, April 28, 2026 /PRNewswire/ — Genezen, a gene therapy contract development and manufacturing organization (CDMO), and The Charlotte & Gwenyth… Login to continue reading Login…

Read MoreGenezen and The Charlotte & Gwenyth Gray Foundation to Cure Batten Disease Announce Manufacturing Partnership for CLN6 Gene Therapy Clinical Trial

Symend and Walnut Launch SymendPrevent: Making Bill Payment Protection the New Standard to Prevent Churn in Essential Services

B First behavioral-science-led distribution model for embedded bill payment protection — launched as households across North America and the UK face record financial stress. CALGARY,… Login to continue reading Login…

Read MoreSymend and Walnut Launch SymendPrevent: Making Bill Payment Protection the New Standard to Prevent Churn in Essential Services